- Home
- IMAX vs OCUL Comparison
IMAX vs OCUL Comparison
Compare IMAX & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAX
- OCUL
- Stock Information
- Founded
- IMAX 1967
- OCUL 2006
- Country
- IMAX Canada
- OCUL United States
- Employees
- IMAX N/A
- OCUL N/A
- Industry
- IMAX
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- IMAX
- OCUL Health Care
- Exchange
- IMAX Nasdaq
- OCUL Nasdaq
- Market Cap
- IMAX 1.3B
- OCUL 1.2B
- IPO Year
- IMAX 1994
- OCUL 2014
- Fundamental
- Price
- IMAX $26.02
- OCUL $7.00
- Analyst Decision
- IMAX Strong Buy
- OCUL Strong Buy
- Analyst Count
- IMAX 11
- OCUL 7
- Target Price
- IMAX $29.55
- OCUL $16.71
- AVG Volume (30 Days)
- IMAX 766.3K
- OCUL 940.9K
- Earning Date
- IMAX 02-19-2025
- OCUL 03-10-2025
- Dividend Yield
- IMAX N/A
- OCUL N/A
- EPS Growth
- IMAX 4.35
- OCUL N/A
- EPS
- IMAX 0.48
- OCUL N/A
- Revenue
- IMAX $352,208,000.00
- OCUL $61,442,000.00
- Revenue This Year
- IMAX N/A
- OCUL $11.40
- Revenue Next Year
- IMAX $14.07
- OCUL $13.58
- P/E Ratio
- IMAX $54.23
- OCUL N/A
- Revenue Growth
- IMAX N/A
- OCUL 6.45
- 52 Week Low
- IMAX $14.94
- OCUL $4.06
- 52 Week High
- IMAX $27.70
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- IMAX 58.21
- OCUL 31.92
- Support Level
- IMAX $25.02
- OCUL $7.14
- Resistance Level
- IMAX $27.38
- OCUL $7.42
- Average True Range (ATR)
- IMAX 0.84
- OCUL 0.37
- MACD
- IMAX 0.18
- OCUL -0.02
- Stochastic Oscillator
- IMAX 62.90
- OCUL 0.76
About IMAX Imax Corporation
Imax Corp is a premier global technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers a unique end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. Top filmmakers, movie studios, artists, and creators utilize the cutting-edge visual and sound technology of IMAX to connect with audiences in innovative ways. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.